Business Context and Reporting Period
AEVEX Corp. (AVEX) filed a Form 8-K on August 12, 2026, announcing the entry into a Material Definitive Agreement to acquire Maritime Applied Physics Corporation (the "Target"). The transaction involves a complex restructuring and merger intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
Key Financial Metrics and Transaction Terms
- Total Enterprise Value: $600,000,000, subject to customary adjustments for net working capital, cash, indebtedness, and transaction expenses.
- Consideration Structure:
- Equity: 12,727,273 shares of Class A common stock (valued at $350,000,000 based on a $27.50 per share price), subject to a 19.99% ownership cap.
- Cash: The remainder of the consideration after deducting the equity value and a $5,000,000 escrow amount.
- Escrow: $5,000,000 deposited to secure post-closing adjustments.
- Contingent Consideration: Up to $50,000,000 payable in additional shares if specific stock price and performance targets are met by December 31, 2027.
- Financing: The cash portion is to be funded by cash on hand and existing credit facilities; the deal is not conditioned on new financing.
Material Changes and Performance Targets
The filing does not report historical financial changes for AEVEX Corp. or the Target for a prior period. However, the contingent consideration is tied to specific future performance metrics for the Target's autonomous vessels (GARC, CHASER, COMET) under U.S. government contracts during the period ending December 31, 2027:
- Scenario A: At least $24,750,000 in revenue and $8,910,000 in gross profit from GARC or CHASER vessels.
- Scenario B: At least $26,630,000 in revenue and $9,570,000 in gross profit from GARC, CHASER, or COMET vessels.
- Stock Price Condition: The 30-trading-day volume weighted average price of AEVEX shares must equal or exceed $28.00 during any 30 consecutive trading days within the earn-out period.
Guidance, Risks, and Contingencies
Closing Conditions: The transaction is subject to customary conditions, including antitrust clearances (Hart-Scott-Rodino), NYSE listing approval, and the absence of a Material Adverse Effect. No stockholder vote is required.
Risks and Uncertainties:
- Failure to obtain regulatory approvals or satisfy closing conditions.
- Potential disruption to current business operations and retention of key employees.
- Dilution of existing shareholders' ownership interests.
- Uncertainty regarding the timing of the closing (agreement allows termination if not closed within 90 days).
Forward-Looking Statements: The filing includes standard safe harbor language noting that actual results may differ materially from projections due to various risks.
Investor Verification Checklist
- Verify the final closing date and whether the 90-day termination window is extended.
- Confirm the receipt of all required regulatory and antitrust approvals.
- Monitor the NYSE listing approval for the new shares to be issued.
- Review the upcoming pro forma financial information (to be filed within 71 days) to assess the impact on AEVEX's balance sheet and liquidity.
- Track the Target's progress on U.S. government contracts to evaluate the likelihood of earning the $50,000,000 contingent consideration.